Clinical Trial Update: Trial on Profermin and Fresubin in Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update announces the completion of Phase 2 and Phase 3 studies evaluating Profermin and Fresubin in patients with ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Fresubin
• Profermin

Snippet

Sponsor: Nordisk Rebalance A/S | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: COMPLETED